abstract |
The present invention relates to inhibitors of HIF-2α and to methods for their preparation and use for the treatment of malignant tumors. Certain compounds were active in a HIF-2α scintillation assay, a luciferase assay and VEGF ELISA assay, and resulted in a reduction in the size and regression of tumors in in vivo 786-O mice. |